CEFOTAXIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefotaxime, and what generic alternatives are available?
Cefotaxime is a drug marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira, Hospira Inc, and Lupin. and is included in fourteen NDAs.
The generic ingredient in CEFOTAXIME is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFOTAXIME?
- What are the global sales for CEFOTAXIME?
- What is Average Wholesale Price for CEFOTAXIME?
Summary for CEFOTAXIME
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 37 |
| Patent Applications: | 3,545 |
| DailyMed Link: | CEFOTAXIME at DailyMed |
Recent Clinical Trials for CEFOTAXIME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | Phase 4 |
| Cairo University | Phase 4 |
| Dr. Promise Tamunoipiriala Jaja | Phase 2 |
Pharmacology for CEFOTAXIME
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFOTAXIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065124-001 | Sep 24, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wockhardt | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065197-003 | Jun 20, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 064200-002 | Mar 24, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 203132-001 | Feb 19, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065292-001 | Aug 10, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 065072-003 | Nov 20, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | CEFOTAXIME | cefotaxime sodium | INJECTABLE;INJECTION | 064201-002 | Mar 24, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
